nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—H1F0—semen—hepatitis B	0.0196	0.227	CbGeAlD
Ziprasidone—Flank pain—Telbivudine—hepatitis B	0.0159	0.0204	CcSEcCtD
Ziprasidone—Gastrointestinal discomfort—Lamivudine—hepatitis B	0.0159	0.0204	CcSEcCtD
Ziprasidone—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0122	0.0157	CcSEcCtD
Ziprasidone—Hepatic steatosis—Lamivudine—hepatitis B	0.0119	0.0154	CcSEcCtD
Ziprasidone—Loose stools—Telbivudine—hepatitis B	0.0115	0.0149	CcSEcCtD
Ziprasidone—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.0111	0.0143	CcSEcCtD
Ziprasidone—Hepatomegaly—Entecavir—hepatitis B	0.011	0.0142	CcSEcCtD
Ziprasidone—Myopathy—Adefovir Dipivoxil—hepatitis B	0.0108	0.0139	CcSEcCtD
Ziprasidone—Glycosuria—Entecavir—hepatitis B	0.0096	0.0124	CcSEcCtD
Ziprasidone—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00937	0.0121	CcSEcCtD
Ziprasidone—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00929	0.012	CcSEcCtD
Ziprasidone—Myopathy—Telbivudine—hepatitis B	0.00911	0.0117	CcSEcCtD
Ziprasidone—Hepatomegaly—Telbivudine—hepatitis B	0.00903	0.0116	CcSEcCtD
Ziprasidone—Fungal skin infection—Lamivudine—hepatitis B	0.00862	0.0111	CcSEcCtD
Ziprasidone—Cough increased—Adefovir Dipivoxil—hepatitis B	0.00829	0.0107	CcSEcCtD
Ziprasidone—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00797	0.0103	CcSEcCtD
Ziprasidone—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00746	0.0096	CcSEcCtD
Ziprasidone—Rhabdomyolysis—Telbivudine—hepatitis B	0.00722	0.0093	CcSEcCtD
Ziprasidone—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00712	0.00917	CcSEcCtD
Ziprasidone—Suicide—Lamivudine—hepatitis B	0.00694	0.00894	CcSEcCtD
Ziprasidone—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00685	0.00882	CcSEcCtD
Ziprasidone—Suicide attempt—Lamivudine—hepatitis B	0.00635	0.00817	CcSEcCtD
Ziprasidone—Gingival bleeding—Lamivudine—hepatitis B	0.00635	0.00817	CcSEcCtD
Ziprasidone—Pregnancy—Lamivudine—hepatitis B	0.00635	0.00817	CcSEcCtD
Ziprasidone—Completed suicide—Lamivudine—hepatitis B	0.00613	0.00789	CcSEcCtD
Ziprasidone—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00579	0.00745	CcSEcCtD
Ziprasidone—Respiratory tract infection—Lamivudine—hepatitis B	0.00573	0.00738	CcSEcCtD
Ziprasidone—Sepsis—Telbivudine—hepatitis B	0.00555	0.00714	CcSEcCtD
Ziprasidone—Blood creatinine increased—Entecavir—hepatitis B	0.00529	0.00681	CcSEcCtD
Ziprasidone—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00523	0.00674	CcSEcCtD
Ziprasidone—SLC6A4—blood plasma—hepatitis B	0.0052	0.06	CbGeAlD
Ziprasidone—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00516	0.00665	CcSEcCtD
Ziprasidone—Myopathy—Lamivudine—hepatitis B	0.00514	0.00661	CcSEcCtD
Ziprasidone—Hepatomegaly—Lamivudine—hepatitis B	0.00509	0.00655	CcSEcCtD
Ziprasidone—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00509	0.00655	CcSEcCtD
Ziprasidone—Throat sore—Lamivudine—hepatitis B	0.005	0.00643	CcSEcCtD
Ziprasidone—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00495	0.00638	CcSEcCtD
Ziprasidone—Renal impairment—Telbivudine—hepatitis B	0.00487	0.00628	CcSEcCtD
Ziprasidone—Amblyopia—Lamivudine—hepatitis B	0.00466	0.00601	CcSEcCtD
Ziprasidone—Pain in extremity—Telbivudine—hepatitis B	0.00464	0.00597	CcSEcCtD
Ziprasidone—HTR1A—blood plasma—hepatitis B	0.00462	0.0533	CbGeAlD
Ziprasidone—Upper respiratory tract infection—Entecavir—hepatitis B	0.00454	0.00584	CcSEcCtD
Ziprasidone—HTR7—blood plasma—hepatitis B	0.00442	0.0509	CbGeAlD
Ziprasidone—Hyperglycaemia—Entecavir—hepatitis B	0.0044	0.00567	CcSEcCtD
Ziprasidone—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00431	0.00555	CcSEcCtD
Ziprasidone—Acne—Lamivudine—hepatitis B	0.00428	0.00551	CcSEcCtD
Ziprasidone—Renal failure—Entecavir—hepatitis B	0.00428	0.00551	CcSEcCtD
Ziprasidone—Cramp muscle—Telbivudine—hepatitis B	0.00418	0.00538	CcSEcCtD
Ziprasidone—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00417	0.00537	CcSEcCtD
Ziprasidone—Haematuria—Entecavir—hepatitis B	0.00415	0.00534	CcSEcCtD
Ziprasidone—Nasopharyngitis—Telbivudine—hepatitis B	0.00415	0.00534	CcSEcCtD
Ziprasidone—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00414	0.00533	CcSEcCtD
Ziprasidone—Gastritis—Telbivudine—hepatitis B	0.00411	0.00529	CcSEcCtD
Ziprasidone—Vasodilation procedure—Lamivudine—hepatitis B	0.0041	0.00528	CcSEcCtD
Ziprasidone—Vasodilation—Lamivudine—hepatitis B	0.0041	0.00528	CcSEcCtD
Ziprasidone—Rhabdomyolysis—Lamivudine—hepatitis B	0.00407	0.00524	CcSEcCtD
Ziprasidone—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00405	0.00521	CcSEcCtD
Ziprasidone—Influenza—Telbivudine—hepatitis B	0.00401	0.00516	CcSEcCtD
Ziprasidone—Rectal haemorrhage—Lamivudine—hepatitis B	0.00399	0.00513	CcSEcCtD
Ziprasidone—Oropharyngeal pain—Lamivudine—hepatitis B	0.00396	0.0051	CcSEcCtD
Ziprasidone—Hepatitis—Entecavir—hepatitis B	0.00391	0.00503	CcSEcCtD
Ziprasidone—Drug interaction—Lamivudine—hepatitis B	0.00388	0.005	CcSEcCtD
Ziprasidone—Oedema peripheral—Entecavir—hepatitis B	0.00385	0.00496	CcSEcCtD
Ziprasidone—Abdominal discomfort—Telbivudine—hepatitis B	0.00384	0.00495	CcSEcCtD
Ziprasidone—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00381	0.00491	CcSEcCtD
Ziprasidone—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00381	0.0049	CcSEcCtD
Ziprasidone—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00378	0.00487	CcSEcCtD
Ziprasidone—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00376	0.00485	CcSEcCtD
Ziprasidone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00375	0.00482	CcSEcCtD
Ziprasidone—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00374	0.00481	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00373	0.0048	CcSEcCtD
Ziprasidone—Muscle twitching—Lamivudine—hepatitis B	0.00367	0.00472	CcSEcCtD
Ziprasidone—Immune system disorder—Entecavir—hepatitis B	0.00353	0.00454	CcSEcCtD
Ziprasidone—CYP1A2—blood plasma—hepatitis B	0.00352	0.0406	CbGeAlD
Ziprasidone—Renal failure—Telbivudine—hepatitis B	0.00351	0.00453	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Telbivudine—hepatitis B	0.0035	0.00451	CcSEcCtD
Ziprasidone—Alopecia—Entecavir—hepatitis B	0.00345	0.00445	CcSEcCtD
Ziprasidone—Mental disorder—Entecavir—hepatitis B	0.00342	0.00441	CcSEcCtD
Ziprasidone—Malnutrition—Entecavir—hepatitis B	0.0034	0.00438	CcSEcCtD
Ziprasidone—CYP3A5—blood plasma—hepatitis B	0.0034	0.0392	CbGeAlD
Ziprasidone—Neuropathy—Lamivudine—hepatitis B	0.00338	0.00435	CcSEcCtD
Ziprasidone—Photophobia—Lamivudine—hepatitis B	0.00338	0.00435	CcSEcCtD
Ziprasidone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00332	0.00427	CcSEcCtD
Ziprasidone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00327	0.00421	CcSEcCtD
Ziprasidone—Urine output increased—Lamivudine—hepatitis B	0.00326	0.00419	CcSEcCtD
Ziprasidone—ADRA2A—blood plasma—hepatitis B	0.00324	0.0374	CbGeAlD
Ziprasidone—Gynaecomastia—Lamivudine—hepatitis B	0.00322	0.00415	CcSEcCtD
Ziprasidone—Back pain—Adefovir Dipivoxil—hepatitis B	0.00321	0.00413	CcSEcCtD
Ziprasidone—Hepatitis—Telbivudine—hepatitis B	0.00321	0.00413	CcSEcCtD
Ziprasidone—Hypoaesthesia—Telbivudine—hepatitis B	0.00319	0.00411	CcSEcCtD
Ziprasidone—Pharyngitis—Telbivudine—hepatitis B	0.00319	0.0041	CcSEcCtD
Ziprasidone—Connective tissue disorder—Telbivudine—hepatitis B	0.00315	0.00406	CcSEcCtD
Ziprasidone—Sepsis—Lamivudine—hepatitis B	0.00313	0.00402	CcSEcCtD
Ziprasidone—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00307	0.00395	CcSEcCtD
Ziprasidone—Lymphadenopathy—Lamivudine—hepatitis B	0.00306	0.00395	CcSEcCtD
Ziprasidone—Leukopenia—Entecavir—hepatitis B	0.00304	0.00392	CcSEcCtD
Ziprasidone—Phlebitis—Lamivudine—hepatitis B	0.00303	0.00391	CcSEcCtD
Ziprasidone—Polyuria—Lamivudine—hepatitis B	0.00298	0.00383	CcSEcCtD
Ziprasidone—Cough—Adefovir Dipivoxil—hepatitis B	0.0029	0.00373	CcSEcCtD
Ziprasidone—Mediastinal disorder—Telbivudine—hepatitis B	0.00289	0.00372	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00288	0.0037	CcSEcCtD
Ziprasidone—Injury—Lamivudine—hepatitis B	0.00284	0.00366	CcSEcCtD
Ziprasidone—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00283	0.00364	CcSEcCtD
Ziprasidone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00283	0.00364	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00281	0.00361	CcSEcCtD
Ziprasidone—Malnutrition—Telbivudine—hepatitis B	0.00279	0.0036	CcSEcCtD
Ziprasidone—CYP3A7—liver—hepatitis B	0.00276	0.0319	CbGeAlD
Ziprasidone—Infection—Entecavir—hepatitis B	0.00276	0.00355	CcSEcCtD
Ziprasidone—HTR2A—blood plasma—hepatitis B	0.00275	0.0318	CbGeAlD
Ziprasidone—Renal impairment—Lamivudine—hepatitis B	0.00275	0.00354	CcSEcCtD
Ziprasidone—Thirst—Lamivudine—hepatitis B	0.00275	0.00354	CcSEcCtD
Ziprasidone—Nervous system disorder—Entecavir—hepatitis B	0.00272	0.0035	CcSEcCtD
Ziprasidone—Back pain—Telbivudine—hepatitis B	0.0027	0.00348	CcSEcCtD
Ziprasidone—Skin disorder—Entecavir—hepatitis B	0.0027	0.00347	CcSEcCtD
Ziprasidone—Muscle spasms—Telbivudine—hepatitis B	0.00269	0.00346	CcSEcCtD
Ziprasidone—Hypoglycaemia—Lamivudine—hepatitis B	0.00268	0.00345	CcSEcCtD
Ziprasidone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00266	0.00342	CcSEcCtD
Ziprasidone—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00265	0.00341	CcSEcCtD
Ziprasidone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00263	0.00339	CcSEcCtD
Ziprasidone—H1F0—blood—hepatitis B	0.00262	0.0302	CbGeAlD
Ziprasidone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00258	0.00332	CcSEcCtD
Ziprasidone—CYP3A4—blood plasma—hepatitis B	0.00255	0.0294	CbGeAlD
Ziprasidone—Insomnia—Entecavir—hepatitis B	0.00251	0.00323	CcSEcCtD
Ziprasidone—CYP2D6—blood plasma—hepatitis B	0.00251	0.0289	CbGeAlD
Ziprasidone—HTR3A—blood—hepatitis B	0.0025	0.0288	CbGeAlD
Ziprasidone—Somnolence—Entecavir—hepatitis B	0.00247	0.00318	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00247	0.00318	CcSEcCtD
Ziprasidone—Dyspepsia—Entecavir—hepatitis B	0.00244	0.00315	CcSEcCtD
Ziprasidone—Cough—Telbivudine—hepatitis B	0.00244	0.00314	CcSEcCtD
Ziprasidone—Dehydration—Lamivudine—hepatitis B	0.00243	0.00313	CcSEcCtD
Ziprasidone—Liver function test abnormal—Lamivudine—hepatitis B	0.00241	0.00311	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Entecavir—hepatitis B	0.0024	0.00309	CcSEcCtD
Ziprasidone—Fatigue—Entecavir—hepatitis B	0.00239	0.00308	CcSEcCtD
Ziprasidone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00238	0.00307	CcSEcCtD
Ziprasidone—Arthralgia—Telbivudine—hepatitis B	0.00238	0.00306	CcSEcCtD
Ziprasidone—Myalgia—Telbivudine—hepatitis B	0.00238	0.00306	CcSEcCtD
Ziprasidone—Chest pain—Telbivudine—hepatitis B	0.00238	0.00306	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00236	0.00304	CcSEcCtD
Ziprasidone—Cramp muscle—Lamivudine—hepatitis B	0.00235	0.00303	CcSEcCtD
Ziprasidone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00235	0.00303	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—liver—hepatitis B	0.00235	0.0271	CbGeAlD
Ziprasidone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00234	0.00301	CcSEcCtD
Ziprasidone—Nasopharyngitis—Lamivudine—hepatitis B	0.00234	0.00301	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Entecavir—hepatitis B	0.00227	0.00292	CcSEcCtD
Ziprasidone—Influenza—Lamivudine—hepatitis B	0.00226	0.00291	CcSEcCtD
Ziprasidone—Dysphagia—Lamivudine—hepatitis B	0.00226	0.00291	CcSEcCtD
Ziprasidone—Nervous system disorder—Telbivudine—hepatitis B	0.00224	0.00288	CcSEcCtD
Ziprasidone—Thrombocytopenia—Telbivudine—hepatitis B	0.00223	0.00287	CcSEcCtD
Ziprasidone—Skin disorder—Telbivudine—hepatitis B	0.00221	0.00285	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00221	0.00285	CcSEcCtD
Ziprasidone—Sweating increased—Lamivudine—hepatitis B	0.0022	0.00283	CcSEcCtD
Ziprasidone—Abdominal pain—Entecavir—hepatitis B	0.00219	0.00283	CcSEcCtD
Ziprasidone—Body temperature increased—Entecavir—hepatitis B	0.00219	0.00283	CcSEcCtD
Ziprasidone—Abdominal discomfort—Lamivudine—hepatitis B	0.00217	0.00279	CcSEcCtD
Ziprasidone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00214	0.00276	CcSEcCtD
Ziprasidone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00214	0.00276	CcSEcCtD
Ziprasidone—Dysuria—Lamivudine—hepatitis B	0.00211	0.00272	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00208	0.00267	CcSEcCtD
Ziprasidone—Insomnia—Telbivudine—hepatitis B	0.00206	0.00266	CcSEcCtD
Ziprasidone—H1F0—liver—hepatitis B	0.00205	0.0237	CbGeAlD
Ziprasidone—Paraesthesia—Telbivudine—hepatitis B	0.00205	0.00264	CcSEcCtD
Ziprasidone—Hyperglycaemia—Lamivudine—hepatitis B	0.00204	0.00262	CcSEcCtD
Ziprasidone—Dyspepsia—Telbivudine—hepatitis B	0.00201	0.00258	CcSEcCtD
Ziprasidone—Asthenia—Entecavir—hepatitis B	0.00199	0.00256	CcSEcCtD
Ziprasidone—Renal failure—Lamivudine—hepatitis B	0.00198	0.00255	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Lamivudine—hepatitis B	0.00198	0.00254	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00197	0.00253	CcSEcCtD
Ziprasidone—Fatigue—Telbivudine—hepatitis B	0.00197	0.00253	CcSEcCtD
Ziprasidone—Jaundice—Lamivudine—hepatitis B	0.00196	0.00253	CcSEcCtD
Ziprasidone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00194	0.0025	CcSEcCtD
Ziprasidone—Sweating—Lamivudine—hepatitis B	0.00193	0.00249	CcSEcCtD
Ziprasidone—SLC6A4—blood—hepatitis B	0.00191	0.022	CbGeAlD
Ziprasidone—Epistaxis—Lamivudine—hepatitis B	0.0019	0.00245	CcSEcCtD
Ziprasidone—Diarrhoea—Entecavir—hepatitis B	0.0019	0.00245	CcSEcCtD
Ziprasidone—Feeling abnormal—Telbivudine—hepatitis B	0.00188	0.00242	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00186	0.0024	CcSEcCtD
Ziprasidone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00185	0.00239	CcSEcCtD
Ziprasidone—Dizziness—Entecavir—hepatitis B	0.00184	0.00236	CcSEcCtD
Ziprasidone—Rhinitis—Lamivudine—hepatitis B	0.00181	0.00233	CcSEcCtD
Ziprasidone—Hepatitis—Lamivudine—hepatitis B	0.00181	0.00233	CcSEcCtD
Ziprasidone—Abdominal pain—Telbivudine—hepatitis B	0.0018	0.00232	CcSEcCtD
Ziprasidone—Body temperature increased—Telbivudine—hepatitis B	0.0018	0.00232	CcSEcCtD
Ziprasidone—Hypoaesthesia—Lamivudine—hepatitis B	0.0018	0.00232	CcSEcCtD
Ziprasidone—Pharyngitis—Lamivudine—hepatitis B	0.0018	0.00231	CcSEcCtD
Ziprasidone—Connective tissue disorder—Lamivudine—hepatitis B	0.00178	0.00229	CcSEcCtD
Ziprasidone—Vomiting—Entecavir—hepatitis B	0.00176	0.00227	CcSEcCtD
Ziprasidone—Rash—Entecavir—hepatitis B	0.00175	0.00225	CcSEcCtD
Ziprasidone—Dermatitis—Entecavir—hepatitis B	0.00175	0.00225	CcSEcCtD
Ziprasidone—Headache—Entecavir—hepatitis B	0.00174	0.00224	CcSEcCtD
Ziprasidone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00172	0.00222	CcSEcCtD
Ziprasidone—Rash—Adefovir Dipivoxil—hepatitis B	0.00171	0.0022	CcSEcCtD
Ziprasidone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00171	0.0022	CcSEcCtD
Ziprasidone—Headache—Adefovir Dipivoxil—hepatitis B	0.0017	0.00218	CcSEcCtD
Ziprasidone—Nausea—Entecavir—hepatitis B	0.00165	0.00212	CcSEcCtD
Ziprasidone—Asthenia—Telbivudine—hepatitis B	0.00164	0.00211	CcSEcCtD
Ziprasidone—Immune system disorder—Lamivudine—hepatitis B	0.00163	0.0021	CcSEcCtD
Ziprasidone—Mediastinal disorder—Lamivudine—hepatitis B	0.00163	0.0021	CcSEcCtD
Ziprasidone—Chills—Lamivudine—hepatitis B	0.00162	0.00209	CcSEcCtD
Ziprasidone—HTR7—blood—hepatitis B	0.00162	0.0187	CbGeAlD
Ziprasidone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00161	0.00207	CcSEcCtD
Ziprasidone—Alopecia—Lamivudine—hepatitis B	0.0016	0.00206	CcSEcCtD
Ziprasidone—Erythema—Lamivudine—hepatitis B	0.00157	0.00203	CcSEcCtD
Ziprasidone—Malnutrition—Lamivudine—hepatitis B	0.00157	0.00203	CcSEcCtD
Ziprasidone—ADRA1A—blood—hepatitis B	0.00156	0.018	CbGeAlD
Ziprasidone—Diarrhoea—Telbivudine—hepatitis B	0.00156	0.00201	CcSEcCtD
Ziprasidone—Flatulence—Lamivudine—hepatitis B	0.00155	0.002	CcSEcCtD
Ziprasidone—Back pain—Lamivudine—hepatitis B	0.00152	0.00196	CcSEcCtD
Ziprasidone—Muscle spasms—Lamivudine—hepatitis B	0.00151	0.00195	CcSEcCtD
Ziprasidone—Dizziness—Telbivudine—hepatitis B	0.00151	0.00194	CcSEcCtD
Ziprasidone—KCNH2—blood—hepatitis B	0.00151	0.0174	CbGeAlD
Ziprasidone—ADRA2C—blood—hepatitis B	0.00149	0.0172	CbGeAlD
Ziprasidone—Tremor—Lamivudine—hepatitis B	0.00148	0.0019	CcSEcCtD
Ziprasidone—Anaemia—Lamivudine—hepatitis B	0.00146	0.00187	CcSEcCtD
Ziprasidone—Vomiting—Telbivudine—hepatitis B	0.00145	0.00187	CcSEcCtD
Ziprasidone—Angioedema—Lamivudine—hepatitis B	0.00144	0.00185	CcSEcCtD
Ziprasidone—Rash—Telbivudine—hepatitis B	0.00144	0.00185	CcSEcCtD
Ziprasidone—Dermatitis—Telbivudine—hepatitis B	0.00144	0.00185	CcSEcCtD
Ziprasidone—Headache—Telbivudine—hepatitis B	0.00143	0.00184	CcSEcCtD
Ziprasidone—Vertigo—Lamivudine—hepatitis B	0.00141	0.00182	CcSEcCtD
Ziprasidone—Syncope—Lamivudine—hepatitis B	0.00141	0.00182	CcSEcCtD
Ziprasidone—Leukopenia—Lamivudine—hepatitis B	0.00141	0.00181	CcSEcCtD
Ziprasidone—Loss of consciousness—Lamivudine—hepatitis B	0.00138	0.00178	CcSEcCtD
Ziprasidone—Cough—Lamivudine—hepatitis B	0.00137	0.00177	CcSEcCtD
Ziprasidone—Nausea—Telbivudine—hepatitis B	0.00135	0.00174	CcSEcCtD
Ziprasidone—Chest pain—Lamivudine—hepatitis B	0.00134	0.00173	CcSEcCtD
Ziprasidone—Arthralgia—Lamivudine—hepatitis B	0.00134	0.00173	CcSEcCtD
Ziprasidone—Myalgia—Lamivudine—hepatitis B	0.00134	0.00173	CcSEcCtD
Ziprasidone—Anxiety—Lamivudine—hepatitis B	0.00134	0.00172	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00133	0.00171	CcSEcCtD
Ziprasidone—Dry mouth—Lamivudine—hepatitis B	0.00131	0.00169	CcSEcCtD
Ziprasidone—Confusional state—Lamivudine—hepatitis B	0.0013	0.00167	CcSEcCtD
Ziprasidone—CYP1A2—blood—hepatitis B	0.00129	0.0149	CbGeAlD
Ziprasidone—Infection—Lamivudine—hepatitis B	0.00128	0.00164	CcSEcCtD
Ziprasidone—HTR7—liver—hepatitis B	0.00126	0.0146	CbGeAlD
Ziprasidone—Shock—Lamivudine—hepatitis B	0.00126	0.00163	CcSEcCtD
Ziprasidone—Nervous system disorder—Lamivudine—hepatitis B	0.00126	0.00162	CcSEcCtD
Ziprasidone—Thrombocytopenia—Lamivudine—hepatitis B	0.00126	0.00162	CcSEcCtD
Ziprasidone—Skin disorder—Lamivudine—hepatitis B	0.00125	0.00161	CcSEcCtD
Ziprasidone—CYP3A5—blood—hepatitis B	0.00124	0.0144	CbGeAlD
Ziprasidone—Hyperhidrosis—Lamivudine—hepatitis B	0.00124	0.0016	CcSEcCtD
Ziprasidone—Anorexia—Lamivudine—hepatitis B	0.00122	0.00158	CcSEcCtD
Ziprasidone—ADRA1A—liver—hepatitis B	0.00122	0.0141	CbGeAlD
Ziprasidone—Hypotension—Lamivudine—hepatitis B	0.0012	0.00155	CcSEcCtD
Ziprasidone—ADRA2A—blood—hepatitis B	0.00119	0.0137	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00117	0.00151	CcSEcCtD
Ziprasidone—ADRA2C—liver—hepatitis B	0.00116	0.0134	CbGeAlD
Ziprasidone—Insomnia—Lamivudine—hepatitis B	0.00116	0.0015	CcSEcCtD
Ziprasidone—Paraesthesia—Lamivudine—hepatitis B	0.00115	0.00149	CcSEcCtD
Ziprasidone—Dyspnoea—Lamivudine—hepatitis B	0.00115	0.00148	CcSEcCtD
Ziprasidone—Somnolence—Lamivudine—hepatitis B	0.00114	0.00147	CcSEcCtD
Ziprasidone—Dyspepsia—Lamivudine—hepatitis B	0.00113	0.00146	CcSEcCtD
Ziprasidone—Decreased appetite—Lamivudine—hepatitis B	0.00112	0.00144	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00111	0.00143	CcSEcCtD
Ziprasidone—Fatigue—Lamivudine—hepatitis B	0.00111	0.00143	CcSEcCtD
Ziprasidone—Constipation—Lamivudine—hepatitis B	0.0011	0.00141	CcSEcCtD
Ziprasidone—Feeling abnormal—Lamivudine—hepatitis B	0.00106	0.00136	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00105	0.00135	CcSEcCtD
Ziprasidone—Urticaria—Lamivudine—hepatitis B	0.00102	0.00131	CcSEcCtD
Ziprasidone—Abdominal pain—Lamivudine—hepatitis B	0.00102	0.00131	CcSEcCtD
Ziprasidone—Body temperature increased—Lamivudine—hepatitis B	0.00102	0.00131	CcSEcCtD
Ziprasidone—CYP1A2—liver—hepatitis B	0.00101	0.0116	CbGeAlD
Ziprasidone—HTR2A—blood—hepatitis B	0.00101	0.0116	CbGeAlD
Ziprasidone—CYP3A5—liver—hepatitis B	0.000973	0.0112	CbGeAlD
Ziprasidone—Hypersensitivity—Lamivudine—hepatitis B	0.000947	0.00122	CcSEcCtD
Ziprasidone—CYP3A4—blood—hepatitis B	0.000934	0.0108	CbGeAlD
Ziprasidone—Asthenia—Lamivudine—hepatitis B	0.000922	0.00119	CcSEcCtD
Ziprasidone—CYP2D6—blood—hepatitis B	0.000919	0.0106	CbGeAlD
Ziprasidone—Diarrhoea—Lamivudine—hepatitis B	0.000879	0.00113	CcSEcCtD
Ziprasidone—Dizziness—Lamivudine—hepatitis B	0.00085	0.00109	CcSEcCtD
Ziprasidone—Vomiting—Lamivudine—hepatitis B	0.000817	0.00105	CcSEcCtD
Ziprasidone—Rash—Lamivudine—hepatitis B	0.00081	0.00104	CcSEcCtD
Ziprasidone—Dermatitis—Lamivudine—hepatitis B	0.00081	0.00104	CcSEcCtD
Ziprasidone—Headache—Lamivudine—hepatitis B	0.000805	0.00104	CcSEcCtD
Ziprasidone—HTR2A—liver—hepatitis B	0.000789	0.0091	CbGeAlD
Ziprasidone—Nausea—Lamivudine—hepatitis B	0.000763	0.000983	CcSEcCtD
Ziprasidone—CYP3A4—liver—hepatitis B	0.00073	0.00843	CbGeAlD
Ziprasidone—CYP2D6—liver—hepatitis B	0.000719	0.00829	CbGeAlD
Ziprasidone—CHRM2—Signaling Pathways—CCR5—hepatitis B	2.44e-05	0.000178	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—IL2—hepatitis B	2.43e-05	0.000178	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCR5—hepatitis B	2.43e-05	0.000178	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL2—hepatitis B	2.43e-05	0.000178	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL2—hepatitis B	2.42e-05	0.000177	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL2—hepatitis B	2.41e-05	0.000177	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL2—hepatitis B	2.41e-05	0.000176	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—F2—hepatitis B	2.38e-05	0.000174	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.38e-05	0.000174	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL2—hepatitis B	2.38e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL2—hepatitis B	2.38e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—ALB—hepatitis B	2.37e-05	0.000173	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GGT1—hepatitis B	2.36e-05	0.000172	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GOT1—hepatitis B	2.36e-05	0.000172	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—F2—hepatitis B	2.35e-05	0.000172	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GOT2—hepatitis B	2.31e-05	0.000169	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TGFB1—hepatitis B	2.27e-05	0.000166	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCR5—hepatitis B	2.26e-05	0.000165	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL2—hepatitis B	2.24e-05	0.000164	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL2—hepatitis B	2.24e-05	0.000164	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—IL6—hepatitis B	2.23e-05	0.000163	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—IL6—hepatitis B	2.23e-05	0.000163	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL2—hepatitis B	2.22e-05	0.000163	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—IL6—hepatitis B	2.21e-05	0.000162	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL2—hepatitis B	2.21e-05	0.000162	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL2—hepatitis B	2.18e-05	0.000159	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—IL6—hepatitis B	2.17e-05	0.000159	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CTNNB1—hepatitis B	2.16e-05	0.000158	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—F2—hepatitis B	2.16e-05	0.000158	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CTNNB1—hepatitis B	2.16e-05	0.000158	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CTNNB1—hepatitis B	2.15e-05	0.000157	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL2—hepatitis B	2.14e-05	0.000157	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—IL6—hepatitis B	2.13e-05	0.000156	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—F2—hepatitis B	2.13e-05	0.000156	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—F2—hepatitis B	2.12e-05	0.000155	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—F2—hepatitis B	2.12e-05	0.000155	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL2—hepatitis B	2.11e-05	0.000155	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CDKN1A—hepatitis B	2.11e-05	0.000155	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CDKN1A—hepatitis B	2.11e-05	0.000155	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—F2—hepatitis B	2.11e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—PTEN—hepatitis B	2.11e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TP53—hepatitis B	2.11e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—PTEN—hepatitis B	2.11e-05	0.000154	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—IL6—hepatitis B	2.1e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CTNNB1—hepatitis B	2.1e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—NFKB1—hepatitis B	2.1e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CDKN1A—hepatitis B	2.1e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—NFKB1—hepatitis B	2.1e-05	0.000153	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—ALB—hepatitis B	2.1e-05	0.000153	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—PTEN—hepatitis B	2.09e-05	0.000153	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—F2—hepatitis B	2.09e-05	0.000153	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—F2—hepatitis B	2.08e-05	0.000153	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—NFKB1—hepatitis B	2.08e-05	0.000152	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CTNNB1—hepatitis B	2.07e-05	0.000151	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CDKN1A—hepatitis B	2.05e-05	0.00015	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—PTEN—hepatitis B	2.05e-05	0.00015	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CTNNB1—hepatitis B	2.04e-05	0.000149	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—NFKB1—hepatitis B	2.04e-05	0.000149	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL2—hepatitis B	2.03e-05	0.000148	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CDKN1A—hepatitis B	2.02e-05	0.000148	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PTEN—hepatitis B	2.02e-05	0.000148	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—hepatitis B	2.02e-05	0.000147	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NFKB1—hepatitis B	2.01e-05	0.000147	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GOT1—hepatitis B	2e-05	0.000146	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GGT1—hepatitis B	2e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CDKN1A—hepatitis B	1.99e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PTEN—hepatitis B	1.99e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NFKB1—hepatitis B	1.98e-05	0.000145	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.97e-05	0.000144	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CTNNB1—hepatitis B	1.96e-05	0.000143	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—F2—hepatitis B	1.94e-05	0.000142	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—hepatitis B	1.93e-05	0.000141	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—hepatitis B	1.93e-05	0.000141	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—hepatitis B	1.92e-05	0.000141	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—hepatitis B	1.92e-05	0.000141	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CDKN1A—hepatitis B	1.91e-05	0.00014	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PTEN—hepatitis B	1.91e-05	0.000139	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—hepatitis B	1.9e-05	0.000139	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NFKB1—hepatitis B	1.9e-05	0.000139	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—hepatitis B	1.89e-05	0.000139	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—hepatitis B	1.87e-05	0.000136	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CTNNB1—hepatitis B	1.86e-05	0.000136	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PTEN—hepatitis B	1.86e-05	0.000136	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CTNNB1—hepatitis B	1.84e-05	0.000135	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CDKN1A—hepatitis B	1.82e-05	0.000133	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.82e-05	0.000133	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PTEN—hepatitis B	1.82e-05	0.000133	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NFKB1—hepatitis B	1.81e-05	0.000132	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PTEN—hepatitis B	1.81e-05	0.000132	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CDKN1A—hepatitis B	1.8e-05	0.000131	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PTEN—hepatitis B	1.79e-05	0.000131	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT2—hepatitis B	1.78e-05	0.000131	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NFKB1—hepatitis B	1.78e-05	0.00013	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—hepatitis B	1.76e-05	0.000129	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—hepatitis B	1.75e-05	0.000128	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—hepatitis B	1.75e-05	0.000128	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—hepatitis B	1.74e-05	0.000127	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—hepatitis B	1.72e-05	0.000126	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—hepatitis B	1.71e-05	0.000125	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—hepatitis B	1.71e-05	0.000125	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—hepatitis B	1.7e-05	0.000124	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—hepatitis B	1.67e-05	0.000122	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CTNNB1—hepatitis B	1.66e-05	0.000121	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—hepatitis B	1.66e-05	0.000121	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—hepatitis B	1.65e-05	0.000121	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—hepatitis B	1.65e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—hepatitis B	1.65e-05	0.000121	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—hepatitis B	1.64e-05	0.00012	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CDKN1A—hepatitis B	1.62e-05	0.000119	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PTEN—hepatitis B	1.62e-05	0.000118	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NFKB1—hepatitis B	1.61e-05	0.000118	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—hepatitis B	1.61e-05	0.000118	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CTNNB1—hepatitis B	1.6e-05	0.000117	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTEN—hepatitis B	1.6e-05	0.000117	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—hepatitis B	1.6e-05	0.000117	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	1.59e-05	0.000117	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—hepatitis B	1.58e-05	0.000116	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—hepatitis B	1.58e-05	0.000116	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—hepatitis B	1.57e-05	0.000115	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CDKN1A—hepatitis B	1.56e-05	0.000115	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PTEN—hepatitis B	1.56e-05	0.000114	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	1.56e-05	0.000114	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NFKB1—hepatitis B	1.55e-05	0.000114	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PTEN—hepatitis B	1.55e-05	0.000114	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CTNNB1—hepatitis B	1.55e-05	0.000113	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NFKB1—hepatitis B	1.55e-05	0.000113	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GGT1—hepatitis B	1.54e-05	0.000113	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT1—hepatitis B	1.54e-05	0.000113	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	1.53e-05	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CDKN1A—hepatitis B	1.51e-05	0.000111	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PTEN—hepatitis B	1.51e-05	0.000111	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—hepatitis B	1.51e-05	0.00011	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NFKB1—hepatitis B	1.5e-05	0.00011	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	1.49e-05	0.000109	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PTEN—hepatitis B	1.49e-05	0.000109	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—hepatitis B	1.49e-05	0.000109	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	1.48e-05	0.000108	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTEN—hepatitis B	1.47e-05	0.000107	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—hepatitis B	1.46e-05	0.000107	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—hepatitis B	1.45e-05	0.000106	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—hepatitis B	1.44e-05	0.000105	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—hepatitis B	1.44e-05	0.000105	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—hepatitis B	1.43e-05	0.000105	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—hepatitis B	1.43e-05	0.000105	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—hepatitis B	1.43e-05	0.000105	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—hepatitis B	1.43e-05	0.000104	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—hepatitis B	1.43e-05	0.000104	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—hepatitis B	1.42e-05	0.000104	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—hepatitis B	1.42e-05	0.000104	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—hepatitis B	1.42e-05	0.000104	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—hepatitis B	1.41e-05	0.000103	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—hepatitis B	1.41e-05	0.000103	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CTNNB1—hepatitis B	1.41e-05	0.000103	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—hepatitis B	1.4e-05	0.000103	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—hepatitis B	1.4e-05	0.000102	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—hepatitis B	1.4e-05	0.000102	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—hepatitis B	1.4e-05	0.000102	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	1.38e-05	0.000101	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CTNNB1—hepatitis B	1.38e-05	0.000101	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CTNNB1—hepatitis B	1.38e-05	0.000101	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—hepatitis B	1.38e-05	0.000101	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1A—hepatitis B	1.37e-05	0.000101	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CTNNB1—hepatitis B	1.37e-05	0.0001	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PTEN—hepatitis B	1.37e-05	0.0001	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NFKB1—hepatitis B	1.36e-05	9.98e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CTNNB1—hepatitis B	1.36e-05	9.94e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—hepatitis B	1.36e-05	9.94e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	1.36e-05	9.92e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	1.35e-05	9.89e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1A—hepatitis B	1.35e-05	9.87e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PTEN—hepatitis B	1.35e-05	9.87e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PTEN—hepatitis B	1.35e-05	9.85e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTEN—hepatitis B	1.34e-05	9.84e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1A—hepatitis B	1.34e-05	9.84e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NFKB1—hepatitis B	1.34e-05	9.82e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PTEN—hepatitis B	1.34e-05	9.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—hepatitis B	1.34e-05	9.81e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1A—hepatitis B	1.34e-05	9.81e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NFKB1—hepatitis B	1.34e-05	9.8e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PTEN—hepatitis B	1.34e-05	9.79e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NFKB1—hepatitis B	1.34e-05	9.77e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NFKB1—hepatitis B	1.33e-05	9.74e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1A—hepatitis B	1.33e-05	9.71e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PTEN—hepatitis B	1.32e-05	9.69e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	1.32e-05	9.69e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PTEN—hepatitis B	1.32e-05	9.67e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NFKB1—hepatitis B	1.32e-05	9.65e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—hepatitis B	1.32e-05	9.64e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—hepatitis B	1.32e-05	9.63e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	1.31e-05	9.62e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—hepatitis B	1.31e-05	9.57e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—hepatitis B	1.3e-05	9.54e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—hepatitis B	1.3e-05	9.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—hepatitis B	1.3e-05	9.5e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—hepatitis B	1.29e-05	9.47e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—hepatitis B	1.29e-05	9.42e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—hepatitis B	1.28e-05	9.37e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—hepatitis B	1.26e-05	9.22e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CTNNB1—hepatitis B	1.26e-05	9.21e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—hepatitis B	1.25e-05	9.17e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—hepatitis B	1.25e-05	9.17e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—hepatitis B	1.24e-05	9.1e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—hepatitis B	1.24e-05	9.07e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	1.23e-05	9.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1A—hepatitis B	1.23e-05	9e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PTEN—hepatitis B	1.23e-05	8.98e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—hepatitis B	1.22e-05	8.95e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NFKB1—hepatitis B	1.22e-05	8.94e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—hepatitis B	1.19e-05	8.71e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—hepatitis B	1.14e-05	8.32e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—hepatitis B	1.13e-05	8.3e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—hepatitis B	1.12e-05	8.19e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—hepatitis B	1.12e-05	8.18e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—hepatitis B	1.12e-05	8.17e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—hepatitis B	1.11e-05	8.14e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—hepatitis B	1.11e-05	8.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—hepatitis B	1.1e-05	8.08e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—hepatitis B	1.1e-05	8.03e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	1.09e-05	8.01e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—hepatitis B	1.07e-05	7.8e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—hepatitis B	1.06e-05	7.77e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—hepatitis B	1.06e-05	7.76e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—hepatitis B	1.03e-05	7.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—hepatitis B	1.02e-05	7.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—hepatitis B	1.01e-05	7.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—hepatitis B	1.01e-05	7.39e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—hepatitis B	9.75e-06	7.14e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—hepatitis B	9.7e-06	7.1e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTEN—hepatitis B	9.56e-06	7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—hepatitis B	9.44e-06	6.91e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—hepatitis B	9.36e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—hepatitis B	9.29e-06	6.8e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—hepatitis B	9.21e-06	6.74e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—hepatitis B	9.19e-06	6.72e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—hepatitis B	9.16e-06	6.7e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—hepatitis B	9.13e-06	6.68e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—hepatitis B	9.04e-06	6.61e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—hepatitis B	9.01e-06	6.6e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—hepatitis B	8.56e-06	6.27e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—hepatitis B	8.43e-06	6.17e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—hepatitis B	8.41e-06	6.15e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—hepatitis B	8.38e-06	6.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—hepatitis B	8.38e-06	6.13e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—hepatitis B	8.35e-06	6.11e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—hepatitis B	8.27e-06	6.05e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—hepatitis B	8.25e-06	6.04e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—hepatitis B	8.2e-06	6e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTEN—hepatitis B	8.1e-06	5.93e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—hepatitis B	7.67e-06	5.61e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTEN—hepatitis B	6.25e-06	4.58e-05	CbGpPWpGaD
